Invention Grant
- Patent Title: Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
-
Application No.: US15818826Application Date: 2017-11-21
-
Publication No.: US10227340B2Publication Date: 2019-03-12
- Inventor: Venkatram Reddy Paidi , Sreekantha Ratna Kumar , Abhisek Banerjee , Ramesh Kumar Sistla , Satheesh Kesavan Nair , William J. Pitts , John Hynes
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary Greenblatt
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D413/14 ; C07D413/04 ; C07D417/04 ; C07D471/04 ; C07D487/04
Abstract:
Compounds having the following formula: or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.
Public/Granted literature
- US20180072712A1 THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2018-03-15
Information query
